Posttraumatic stress disorder (PTSD) symptoms and pain after traumatic events such as motor vehicle collision (MVC) have been proposed to be mutually promoting. We performed a prospective multicenter study that enrolled 948 individuals who presented to the emergency department within 24 hours of MVC and were discharged home after evaluation. Follow-up evaluations were completed 6 weeks, 6 months, and 1 year after MVC. Path analysis results supported the hypothesis that axial pain after MVC consistently promotes the maintenance of hyperarousal and intrusive symptoms, from the early weeks after injury through 1 year. In addition, path analysis results supported the hypothesis that one or more PTSD symptom clusters had an influence on axial pain outcomes throughout the year after MVC, with hyperarousal symptoms most influencing axial pain persistence in the initial months after MVC. The influence of hyperarousal symptoms on pain persistence was only present among individuals with genetic vulnerability to stress-induced pain, suggesting specific mechanisms by which hyperarousal symptoms may lead to hyperalgesia and allodynia. Further studies are needed to better understand the specific mechanisms by which pain and PTSD symptoms enhance one another after trauma, and how such mechanisms vary among specific patient subgroups, to better inform the development of secondary preventive interventions.
Introduction
Motor vehicle collision (MVC) results in 50 million injuries worldwide and almost 4 million US emergency department (ED) visits each year. 32, 46 In the United States, more than 90% of individuals presenting to the ED after MVC are discharged home after evaluation. 34 A substantial proportion of these individuals develop persistent musculoskeletal pain, 28 and the most common and morbid location of such pain is the axial region (neck, shoulders, and/or back). 8 Posttraumatic stress disorder (PTSD) symptoms including reexperiencing the MVC, avoidance of reminders of the MVC, and hyperarousal symptoms are also common in this population and have been hypothesized to contribute to pain persistence through a number of mechanisms. 30, 38 Re-experiencing may disrupt cognitive efforts to reduce pain perception and facilitate recovery, or may drive the activation of stress systems which alter neurosensory processing. 29, 36, 37 Avoidance and associated withdrawal from usual activities may promote disuse and disability, contributing to pain persistence. 22, 36, 44 Hyperarousal may lead to alterations in muscle use and persistent biomechanical changes which result in persistent pain, 22, 26 and may drive the activation of stress systems which alter neurosensory processing. 29 Attentional bias due to hyperarousal may also directly augment pain experiences. 3, 22, 27 In this study, we used a path-analytic approach to evaluate whether longitudinal relationships between posttraumatic stress and axial pain symptoms after MVC support the hypothesis that one or more PTSD symptom clusters promote axial pain persistence. To our knowledge, such an analysis has not previously been performed. Based on the existing evidence from other settings that hyperarousal and re-experiencing symptoms have the greatest influence on pain outcomes and that such symptoms may partially mediate the association between acute Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
and chronic pain, 21, 23, 27 we hypothesized that hyperarousal and re-experiencing symptoms would partially mediate post-MVC axial pain persistence. In addition, based on the concept that hyperarousal symptoms reflect and/or drive continued stress system activation, we hypothesized that increased hyperarousal symptoms would more strongly predict increased pain among individuals with increased genetic vulnerability to stress-induced pain. To evaluate this hypothesis, we explored the relationship between hyperarousal and axial pain persistence among individuals with glucocorticoid receptor co-chaperone FK506-binding protein 51 (FKBP5) haplotypes that are known to increase vulnerability to chronic post-MVC pain. 9 In secondary analyses, we also explored path differences over time among those with and without substantial early and persistent PTSD or axial pain symptoms.
Methods

Design and setting
This prospective longitudinal study enrolled patients presenting to the ED within 24 hours of MVC. Data were collected at 8 EDs in 4 no-fault MVC litigation/insurance states (Michigan, Massachusetts, New York, and Florida) between February 2009 and October 2011. The study was approved by the institutional review boards of all participating hospitals, and each participant provided written informed consent. Complete information regarding study design, procedures, and methods has previously been described. 33 
Participant eligibility criteria and study sites
Patients aged 18 to 65 years who presented to the ED within 24 hours after a MVC and were unlikely to require hospitalization were screened for eligibility. Patients who were admitted to the hospital, had fractures other than phalangeal fractures, had more than 4 lacerations requiring sutures or a single laceration more than 20 cm in length, or had intracranial or spinal injuries were excluded. Spinal injury was defined by the presence of a fracture, dislocation, or new neurologic deficit. Enrollment was limited to non-Hispanic whites (the most common ethnicity at study sites) because the study included the collection of genetic data and genetic analyses are potentially biased by population stratification. 13 Patients who were not alert and oriented were also excluded, as were pregnant patients, prisoners, patients unable to read and understand English, patients taking a b-adrenoreceptor antagonist, or patients taking opioids above a total daily dose of 20 mg of oral morphine or equivalent.
Study procedures
Eligible and consenting participants completed ED interview evaluations that included an assessment of baseline demographic characteristics and current symptoms. These assessments were conducted by research assistants using a web-based survey with explicit definitions of variables. Before enrolling patients in the ED, each research assistant completed a study training module followed by an interview with a standardized mock ED patient.
Comparison of mock ED patient data across research assistants demonstrated an error rate of 1.3%. Injury characteristics and medications administered in the ED were extracted from the medical record. Six weeks, 6 months, and 1 year after the MVC, participants completed a follow-up interview online, by telephone, or through mail. Participants were compensated $80 for completing the ED interview, $50 for completing the 6-week interview, $60 for completing the 6-month interview, and $70 for completing the 12-month interview.
Measures
Study measures are described below, and complete study measures are described in full elsewhere. 33 
Participant demographics
Participant demographic characteristics (including age, sex, income, height, weight, and educational attainment) were obtained from participant self-report and the ED medical record.
Pain assessments and pain outcome definitions
Pain extent and severity were assessed in the ED and at 6 weeks, 6 months, and 1 year. In each of the 19 discrete body regions in which the participant reported pain, pain severity was assessed using a verbal 0 to 10 numeric rating scale. If a participant reported pain in a body region (numeric rating scale score of $1), then they were also asked whether the pain was due to the MVC. Axial pain severity was defined as the maximum pain reported in the neck, left shoulder, right shoulder, upper back region, or lower back region. Axial pain severity $4 was defined as moderate or severe. Participants that experienced non-MVC moderate to severe axial pain were excluded from the analyses to reduce any potential influence of non-MVC-related axial pain (non-MRAP) on PTSD symptoms.
Psychological symptoms
Psychological distress in the ED was assessed using the Peritraumatic Distress Inventory (PDI), which measures peritraumatic distress symptom clusters (life threat, helplessness/anger, loss of control, and guilt/shame). This measure has been found to have high internal consistency (standardized coefficient alpha of 0.75-0.76) and test-retest reliability (coefficient alpha of 0.74) within a general civilian population. 10 A PDI cut-off score of $23 was used to define marked distress symptoms ("distress"). 31 Posttraumatic stress disorder symptoms (intrusion, avoidance, and hyperarousal) were assessed at 6 weeks, 6 months, and 1 year using the Impact of Events Scale-Revised (IES-R). 4 An IES-R score of .30 was used to define the presence of substantial PTSD symptoms. 16 
DNA collection and genotyping
Study personnel collected blood samples at the time of enrollment using PAXgene DNA tubes. After DNA purification (PAXgene blood DNA kit; QIAGEN, Valencia, CA), genotyping using the Sequenom platform (Sequenom, San Diego, CA) was performed at 33 single nucleotide polymorphisms (SNPs) selected to cover haplotype diversity at the FKBP5 gene locus (Fig. 1) . Two Hapmap samples and 2 repeat samples were included in each genotyping batch (96 samples). FKBP5 tag SNPs previously identified using the Tagger procedure in Haploview (r 2 $ 0.8) were selected for gene-by-environment interaction analyses. . We first fit CFA models to assess PDI and IES-R subscales in our samples. We then fit a longitudinal path analysis using these subscales and axial pain outcome data from each timepoint (ie, 52 total free paths). All variables measured at the same timepoint were allowed to correlate freely, as were repeated measurements of the same variable over time. Path models were fit using maximum likelihood methods to allow inclusion of all observed data for those participants who provided incomplete data. After fitting the full model, paths for which P $ 0.05 were sequentially removed (ie, restricted to be zero) to obtain the reduced model. For comparing the model across subgroups of interest (described in section 3.7), we fit multiple-group path analyses in which we initially allowed all path coefficients and other model parameters to vary freely between groups (the completely unrestricted model). We then fit a series of 2 restricted models to explore differences between subgroups: (1) restricting the 6 paths from the PTSD symptom clusters to axial pain severity at the subsequent visit to be the same across the subgroups; (2) restricting the same paths in (1) plus the 6 paths from axial pain severity to the PTSD symptom clusters at subsequent visits to be the same across subgroups. We compared the restricted models to the unrestricted model using x 2 difference tests with 6 or 12 degrees of freedom, respectively. In the event that either x 2 difference test produced a P , 0.05, providing evidence that the less restricted model fits the data better than the more restricted model, we then explored which specific paths differed across subgroups using additional x 2 difference tests, each conducted at the 0.05 significance level.
Results
Sample characteristics
A total of 10,629 patients were screened, 1416 were eligible, 969 consented to study participation, and 948 were enrolled. The median time between MVC and ED presentation was 1.2 hours. Consistent with eligibility criteria, all patients were discharged home after ED evaluation and did not have life-threatening injury. Ninetynine percent of participants had an Abbreviated Injury Scale score of 1. Retention rates at 6 weeks, 6 months, and 1 year were 859/ 948 (91%), 840/948 (89%), and 861/948 (91%), respectively. Study participant characteristics are shown in Table 1 .
Genotyping
Blood was obtained from each of the 948 participants, and DNA was extracted from 946/948 (99.8%). Call rates for genotyping were .99%. Selected repeated genotyping demonstrated .98% call agreement, and all SNPs were in Hardy-Weinberg equilibrium.
Pain and posttraumatic stress disorder symptoms over time
Most participants who reported pain status had moderate or severe axial pain in the ED (660/933, 71%), and greater than 1 in 3 who completed the PDI assessment experienced peritraumatic distress (355/934, 38%) ( Table 1) . At 6 weeks, moderate or severe axial pain was present in 437/809 participants (54%) and 241/856 participants (28%) had substantial PTSD symptoms. At 6 months, 305/759 participants (40%) had moderate or severe axial pain and 145/834 participants (17%) had substantial PTSD symptoms. At 1 year, 276/723 participants (38%) had moderate or severe axial pain and 140/859 participants (16%) had substantial PTSD symptoms (Note: group sizes for these proportions include only those individuals with nonmissing responses at the timepoint for that measure).
Relationship between pain and PDI/posttraumatic stress disorder symptoms over time
The correlation between PTSD symptoms (assessed using the PDI in the ED, and IES-R at subsequent timepoints) and MRAP symptoms increased steadily over time: ED r 5 0.12, 6 week r 5 0.28, 6 month r 5 0.42, and 12 month r 5 0.43 (P , 0.01 at all timepoints). Across all timepoints, moderate or severe axial pain was more common among those with substantial PTSD symptoms than substantial PTSD symptoms were among those with moderate or severe axial pain (Fig. 2) .
Path analysis
Path analysis evaluated the relationship between peritraumatic axial pain and distress symptoms and PTSD symptom clusters and axial pain severity over time (Fig. 3) . 3.5.1. Associations between axial pain severity and subsequent posttraumatic stress disorder symptom cluster severity Axial pain severity generally predicted PTSD symptom clusters at subsequent timepoints (Fig. 3) . Axial pain consistently predicted hyperarousal symptoms at subsequent timepoints, and was more strongly predictive of hyperarousal symptoms than other PTSD symptom clusters (higher b values, data not shown). Axial pain was also consistently linked to intrusive symptoms at subsequent timepoints. Axial pain severity in the ED predicted avoidance symptoms at 6 weeks, but not at later timepoints.
3.5.2. Associations between posttraumatic stress disorder symptom cluster severity and subsequent axial pain severity Peritraumatic helplessness and anger symptoms predicted axial pain 6 weeks after MVC, but peritraumatic life threat, loss of control, and guilt/shame symptoms did not (Fig. 3) . Six-week hyperarousal symptoms predicted axial pain severity at 6 months, as well as all PTSD symptom clusters, whereas 6-week intrusion and avoidance symptoms did not. In contrast, at 6 months intrusive rather than hyperarousal symptoms predicted axial pain at 12 months, and hyperarousal and avoidance symptoms did not. Intrusion and avoidance symptoms at 6 months also predicted PTSD symptom clusters at 12 months.
Posttraumatic stress disorder symptom clusters partially mediating axial pain persistence
Hyperarousal symptoms assessed at 6 weeks partially mediated the relationship between axial pain symptoms in the ED and axial pain symptoms at 6 months (Fig. 3) . The estimated standardized indirect effect of ED axial pain on 6-month axial pain through 6-week axial pain is 0.218 (P , 0.001), and the standardized indirect effect through hyperarousal at 6 weeks is 0.029 (P , 0.001), which indicates significant partial mediation through hyperarousal. Similarly, intrusive symptoms partially mediated the relationship between axial pain at 6 weeks and axial pain at 12 months. The standardized indirect effect of 6-week axial pain on 1-year axial pain through 6-month axial pain is 0.265 (P , 0.001), and the standardized indirect effect through 6-month intrusion is 0.009 (P 5 0.034), which indicates significant partial mediation through intrusion.
Influence of posttraumatic stress disorder symptoms on postmotor vehicle collision axial pain among individuals with genetic vulnerability to stress-induced pain
Among the 460/949 (48%) study participants with increased genetic vulnerability to stress-induced pain (individuals with one or more copies of the FKBP5 risk haplotype 9 ), 6-week hyperarousal symptoms more strongly mediated the relationship between acute axial pain severity and axial pain severity at 6 months (Fig. 4) .
Secondary analyses
Among study participants with substantial peritraumatic distress in the ED (62%), hyperarousal symptoms were less influential in the persistence of axial pain symptoms at 1 year, whereas avoidance symptoms were more influential (Fig. 5) . No differences in the relationship between PTSD symptoms and axial pain were observed among the other subgroups analyzed: those with vs without moderate or severe axial pain in the ED, those with and without persistent PTSD at year 1, those with vs without moderate or severe axial pain at year 1, and in men vs women.
Discussion
In this study, we evaluated longitudinal associations between posttraumatic stress symptoms and axial pain outcomes in a large cohort of individuals experiencing MVC. Both substantial PTSD symptoms and moderate or severe axial pain symptoms were common in the cohort, with more than 1 in 4 participants having substantial PTSD symptoms and 1 in 2 having moderate or severe axial pain symptoms at 6 weeks. The correlation between PTSD and axial pain symptoms increased steadily over time, from 0.12 in the ED to 0.43 at 1 year. Path analysis results support the hypothesis that axial pain after MVC consistently promotes the maintenance of hyperarousal and intrusive symptoms from the early weeks postinjury through 1 year. In contrast, although one or more PTSD symptom clusters had an influence on axial pain outcomes throughout the year after MVC, the different symptom clusters were influential at different timepoints, with helplessness and anger most influencing axial pain severity in the initial weeks after MVC, hyperarousal symptoms most influencing (and partially mediating) axial pain persistence in the initial months after MVC, and intrusive symptoms partially mediating the persistence of axial pain at 1 year. In addition, PTSD symptoms (specifically hyperarousal symptoms) had a greater influence on pain outcomes among individuals with increased genetic vulnerability to stress-induced pain, and relationships between pain and PTSD symptoms vary among those with substantial peritraumatic distress. Our study findings are consistent with previous studies of other trauma populations that found that PTSD symptoms in general, and hyperarousal and intrusive/re-experiencing symptoms in particular, contribute to the development of chronic musculoskeletal pain. Kimerling et al. 21 examined the relationship between war-zone stress exposure, PTSD symptom clusters, and physical symptoms (including neck pain and back pain) among 52 female Vietnam veterans evaluated many years after military service. In this study, PTSD symptoms were found to mediate the relationship between trauma exposure and physical symptom outcomes, with hyperarousal symptoms showing the strongest association. McFarlane et al. 27 assessed a group of Australian firefighters 42 months after a brush fire disaster, and found that individuals with PTSD reported significantly more physical symptoms, including musculoskeletal pain. In this study, re-experiencing symptoms was most strongly associated with physical symptom outcomes. 27 Jenewein et al. 19 assessed 323 hospitalized trauma patients 5 days, 6 months, and 12 months after injury and found that PTSD symptoms influenced pain intensity across timepoints. Liedl et al. assessed 824 hospitalized trauma patients 1 week, 3 months, and 12 months after trauma and found that pain severity 3 and 12 months after trauma was predicted by re-experiencing and hyperarousal at previous timepoints. In addition, 3-month hyperarousal symptoms mediated the relationship between baseline and 12-month pain. 23 To our knowledge, our study is the first to use a path analytic approach to evaluate longitudinal relationships between specific PTSD symptom clusters and axial pain symptoms after time after MVC. Our results build on the findings of Sterling and colleagues, who first identified PTSD symptoms in the early aftermath of MVC as an important predictor of chronic pain. [39] [40] [41] Sterling and colleagues also found that individuals with chronic pain after MVC who have substantial comorbid PTSD symptoms have greater disability, negative affect, pain, arousal, and lower pain thresholds than those without PTSD. 15 Our study design provided the opportunity to evaluate the influence of individual symptom clusters over time, and is broadly consistent with the mutual maintenance model, which proposes that PTSD and pain symptoms are mutually enhancing. 23 However, as noted above, although pain symptoms had a consistent augmenting effect on PTSD symptoms across time, our results indicate that the relative influence of different PTSD symptom clusters may be time dependent. Hyperarousal symptoms most influenced axial pain persistence in the initial months after MVC, and may be most important to target with interventions during this time, with intrusive symptoms playing a greater role in maintaining/ augmenting pain after chronic pain has developed. Importantly, our study results also indicate that constitutional (genetic) factors affect the influence of PTSD symptom clusters on chronic pain pathogenesis. Forty-eight percent of study participants had a genetic variant in the FKBP5 gene that results in increased FKBP5 levels, 7 reduced glucocorticoid receptor sensitivity, 5, 6 and relatively elevated glucocorticoid levels. 18, 42 Among such individuals, the influence of hyperarousal symptoms on pain was much greater. Indeed, among individuals without such a risk allele hyperarousal symptoms had only a negligible effect on pain (Fig. 4) . Animal data indicate that persistently elevated levels of cortisol sensitize primary afferents, 20 and that elevated spinal FKBP5 levels contribute to hypersensitivity and intracellular changes/switches that cause the cellular effects of glucocorticoids to change from analgesic to hyperalgesic. 24 Such molecular switches that cause stress molecules (eg, glucocorticoids) to change from analgesic to hyperalgesic are fundamental to the development of chronic posttraumatic pain. In such individuals, hyperarousal symptoms, a dominant PTSD symptom cluster 25, 35 known to drive the further activation of stress systems including hypothalamic-pituitary-adrenal and Figure 3 . Significant pathways between peritraumatic distress symptom cluster severity (assessed in the emergency department (ED) as life threat, helplessness, loss of control, and guilt/shame) and posttraumatic stress disorder symptom cluster severity (assessed at subsequent timepoints as intrusion, avoidance, and hyperarousal) and motor vehicle collision (MVC)-related axial pain severity across ED, 6 week, 6 month, and 1 year timepoints after MVC. *P , 0.05, **P , 0.01. catecholaminergic systems, 45 may promote the cellular changes that underline chronic pain. In human studies, the above described FKBP5 genetic variants have been associated with vulnerability to chronic pain development after several different traumatic stress exposures 9 ; enhancing the ability of PTSD symptoms to shape chronic pain outcomes may be one mechanism by which these polymorphisms increase susceptibility to chronic pain. Such an effect may be increased among those living in more stressful, low socioeconomic status environments. 43 Our findings add to evidence that interventions to reduce PTSD symptoms in the aftermath of MVC may improve chronic axial pain outcomes. This hypothesis is further supported by evidence that among individuals with chronic axial pain and substantial PTSD symptoms after MVC, interventions targeting PTSD symptoms also improve pain symptoms.
14 Recently, several cognitive-behavioral interventions have been developed to target PTSD symptoms in the early aftermath of MVC, to determine if such interventions can reduce both pain and PTSD symptoms. 1, 11 Such interventions offer exciting new opportunities for interventions to reduce pain and disability after MVC, and may be most efficacious among subgroups of individuals with specific constitutional characteristics and among individuals identifiable by peritraumatic phenotype.
Several limitations must be considered when interpreting our study findings. First, the study population was limited to European Americans (the most common ethnicity at study sites) to avoid potential bias in genetic analyses due to population stratification. The generalizability of our results to other racial/ethnic groups is unknown. Second, to reduce confounding, we excluded data from study participants who reported no MRAP $4 but did report non-MRAP $4. The exclusion of axial pain that was not MVC related was based on the hypothesis that the presence of any axial pain may influence PTSD symptoms, whereas this analysis was focused solely on pain resulting from MVC. However, this choice of methodology may have introduced other forms of bias into the study. Also, posttraumatic stress symptoms were assessed using Figure 4 . Among study participants with one or more copies of the FKBP5 risk haplotype (18%), hyperarousal symptoms had a greater influence on mediating the relationship between acute axial pain and axial pain at 6 months than among other participants (P 5 0.03). *Significant difference between subgroups. MVC, motor vehicle collision. Figure 5 . Among study participants with substantial peritraumatic distress, hyperarousal symptoms had a lesser influence on mediating the relationship between axial pain at 6 weeks and axial pain at 1 year than among other participants (P 5 0.008), and avoidance symptoms had a greater influence on mediating the relationship between axial pain at 6 weeks and axial pain at 1 year (P , 0.001) than among other participants. *Significant difference between subgroups. ED, emergency department; MVC, motor vehicle collision.
the PDI during the peritraumatic period, whereas the IES-R was used at 6 weeks, 6 months, and 12 months. Thus, we are not able to evaluate the influence of PTSD symptom clusters using a common assessment method from the time of trauma. Our study also did not explore the potential role that individual cognitive factors, such as pain catastrophizing, self-rated physical health, and beliefs and expectations around recovery may have had on the associations studied. The literature suggests that such factors contribute to the recovery process after trauma, 17, 28 and they may influence the relationship between pain and PTSD symptoms in the aftermath of trauma exposure. In addition, our study only focused on the influence of posttraumatic stress symptoms on pain symptoms, and did not evaluate the association between posttraumatic stress and pain-related disability or function. Finally, our study focused on the relationship between pain and PTSD symptoms only during the first year after MVC.
The results of this study suggest that axial pain after MVC consistently promotes the maintenance of PTSD symptoms, from the early weeks postinjury through 1 year, and that one or more PTSD symptom clusters had an influence on axial pain outcomes throughout the year after MVC, with hyperarousal symptoms most influencing axial pain persistence in the initial months after MVC. The influence of hyperarousal symptoms on pain persistence was only present among those with genetic vulnerability to stress-induced pain, suggesting specific mechanisms by which hyperarousal symptoms may lead to hyperalgesia and allodynia. Further studies are needed to better understand the interplay of pain and PTSD symptoms during the aftermath of trauma. Such understanding will allow the development of optimal interventions to reduce the incidence of both of these common, highly morbid outcomes.
